Items where Author is "Nomikos, N."

Article

Nomikos, N., Naoum, P., Athanasakis, Kostas and Kyriopoulos, I ORCID: 0000-0002-3932-8228 (2024) Cost-effectiveness analysis of filgotinib as a first-line treatment for biologic-naive patients with Ulcerative Colitis in Greece. Value in Health, 27 (12, Supplement). S80 - S80. ISSN 1098-3015

Nomikos, N., Naoum, P., Athanasakis, K. and Kyriopoulos, I ORCID: 0000-0002-3932-8228 (2024) Cost-effectiveness analysis of filgotinib versus tofacitinib as first-line treatments for rheumatoid arthritis in Greece. Value in Health, 27 (12, Supplement). S80 - S80. ISSN 1098-3015

Nomikos, N., Naoum, P., Athanasakis, K. and Kyriopoulos, I ORCID: 0000-0002-3932-8228 (2024) EE477 A budget impact analysis of introducing filgotinib for the treatment of rheumatoid arthritis in Greece. Value in Health, 27 (12 Supplement). S149. ISSN 1098-3015

Nomikos, N., Naoum, P., Athanasakis, K. and Kyriopoulos, I ORCID: 0000-0002-3932-8228 (2024) EE478 A budget impact analysis of introducing filgotinib as a first-line treatment for moderate to severe ulcerative colitis in Greece. Value in Health, 27 (12 Supplement). S149. ISSN 1098-3015

Zisis, K., Karampli, E., Nomikos, N., Agorastos, I, Naoum, P., Tsiantou, V, Kyriopoulos, I ORCID: 0000-0002-3932-8228 and Pavi, E. (2024) HPR240 A rapid review of key challenges and success factors in implementing managed entry agreements for pharmaceuticals: lessons for Greece. Value in Health, 27 (12, Supplement). S320 - S321. ISSN 1098-3015